Ampersand Biomedicines Inc

Akouos, Inc. is a Boston-based precision genetic medicine company dedicated to developing innovative gene therapies aimed at restoring, improving, and preserving high-acuity hearing for individuals with disabling hearing loss. With a global focus on addressing the underlying causes of hearing loss, the company seeks to meet the significant unmet medical needs affecting 466 million people worldwide. At the core of Akouos's mission is a passionate team committed to collaboration and scientific excellence, emphasizing the importance of listening to one another. Their advanced technology platform is designed to bring the benefits of precision medicine to the inner ear, fostering advancements in hearing health. Generated from the website

Kojin Therapeutics Inc is a biotech company based in Boston, MA, focusing on innovative therapeutic solutions. The organization emphasizes advancements in medical science to address unmet health needs. While the company's specific services and trademarks are not endorsed or associated with any third-party advertisers, Kojin Therapeutics aims to contribute significantly to the healthcare landscape. Their commitment to research and development showcases a dedication to improving patient outcomes. Generated from the website

Roivant Sciences, Inc. is a biotechnology company based in Boston, MA that is dedicated to revolutionizing the discovery, development, and commercialization of new medicines. They achieve this by building agile and focused companies called Vants, which employ technology across all stages of the drug development process. With a track record of 10 positive Phase 3 trials and 6 FDA approvals since 2019, Roivant Sciences is committed to advancing transformative therapies for autoimmune diseases and severe conditions. Through their subsidiaries, such as Immunovant, Dermavant, and Priovant, Roivant Sciences aligns incentives to drive fast and high-quality execution, while also ensuring rigorous capital allocation. Their innovative approach and commitment to developing targeted therapies have earned them recognition, including being named to Fast Company's Best Workplaces for Innovators List. With a broad and differentiated pipeline of investigational drugs, Roivant Sciences is at the forefront of transforming the future of healthcare.Generated from the website